Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

4 results about "Enterohemorrhagic e coli" patented technology

One E. coli strain that causes a severe intestinal infection in humans is known as enterohemorrhagic E. coli (EHEC). It’s the most common strain to cause illness in people. It’s different from other E. coli because it produces a potent toxin called Shiga toxin.

Polyclonal antibody of enterohemorrhagic escherichia coli Intimin protein as well as preparation method and application of polyclonal antibody

The invention relates to a polyclonal antibody of enterohemorrhagic Escherichia coli Intimin protein as well as a preparation method and application of the polyclonal antibody, and the polyclonal antibody of the enterohemorrhagic Escherichia coli Intimin protein can specifically recognize the enterohemorrhagic Escherichia coli Intimin protein and has relatively high titer; according to the present invention, with the enterohemorrhagic Escherichia coli Intimin protein polyclonal antibody, the infection process of enterohemorrhagic Escherichia coli can be deeply understood through the enterohemorrhagic Escherichia coli Intimin protein polyclonal antibody, such that the hereditary basis and the molecular mechanism of the enterohemorrhagic Escherichia coli infection host cell can be further researched; the method has double values for understanding pathogenesis and developing prevention and control means.
Owner:NANKAI UNIV

Reaction media and method for detecting Shiga toxin-producing Escherichia coli and / or enterohemorrhagic Escherichia coli.

PendingJP2026522003ANanoparticleChemical compound
The present invention relates to a gelling reaction medium for the detection, identification, and / or isolation of at least one Shiga toxin-producing Escherichia coli strain, comprising: - at least one toxin inducer; - at least one agglutination conjugate containing at least one specific binding partner of STX1 and / or at least one specific binding partner of STX2, conjugated to nanoparticles; and - a concentration gradient of compounds for inhibiting non-target bacteria. The present invention also relates to related methods for detecting and / or isolating Shiga toxin-producing Escherichia coli that are likely to be present in a sample containing enterobacteria.
Owner:BIOMERIEUX SA